132 related articles for article (PubMed ID: 8589216)
1. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
Carlson TH; Kolman MR; Piepkorn M
Blood Coagul Fibrinolysis; 1995 Jul; 6(5):474-80. PubMed ID: 8589216
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
3. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
Scully MF; Ellis V; Shah N; Kakkar V
Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
[TBL] [Abstract][Full Text] [Related]
4. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
5. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B
Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917
[TBL] [Abstract][Full Text] [Related]
6. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
Hovingh P; Piepkorn M; Linker A
Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
[TBL] [Abstract][Full Text] [Related]
7. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
9. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
Scully MF; Ellis V; Kakkar VV
Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulant properties in vitro of heparan sulphates.
Hubbard AR; Jennings CA; Barrowcliffe TW
Thromb Res; 1984 Sep; 35(5):567-76. PubMed ID: 6237461
[TBL] [Abstract][Full Text] [Related]
11. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.
Fischer AM; Beguin S; Sternberg C; Dautzenberg MD
Br J Haematol; 1987 Jun; 66(2):213-7. PubMed ID: 2955807
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
Pletcher CH; Cunningham M; Nelsestuen GL
Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
[TBL] [Abstract][Full Text] [Related]
14. Heparan sulphate with no affinity for antithrombin III and the control of haemostasis.
Scully MF; Ellis V; Kakkar VV
FEBS Lett; 1988 Dec; 241(1-2):11-4. PubMed ID: 2973992
[TBL] [Abstract][Full Text] [Related]
15. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
Carlson TH; Kolman MR; Frees A; Babcock T
Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
[TBL] [Abstract][Full Text] [Related]
16. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate.
Ofosu FA; Modi GJ; Blajchman MA; Buchanan MR; Johnson EA
Biochem J; 1987 Dec; 248(3):889-96. PubMed ID: 2963622
[TBL] [Abstract][Full Text] [Related]
17. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
Scully MF; Kakkar VV
Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
[TBL] [Abstract][Full Text] [Related]
18. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin.
Dawes J
Anal Biochem; 1988 Oct; 174(1):177-86. PubMed ID: 3218731
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
